Report - Margetuximab (M) and Pembrolizumab (P) in HER2 ... · p=0.023 p=0.043 ERBB2/HER2 Gastric Cancer GEJ Cancer ERBB2 mRNA expression significantly correlated with response, being 5.13

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form